Osteoporosis treatment with denosumab in routine clinical practice in Poland.

Marcinowska-Suchowierska, Ewa; Blicharski, Tomasz; Wielosz, Ewa; Rell-Bakalarska, Maria; Duma, Krzysztof; Paradowska-Kowal, Katarzyna; Sewerynek, Ewa

Marcinowska-Suchowierska, Ewa; Blicharski, Tomasz; Wielosz, Ewa; Rell-Bakalarska, Maria; Duma, Krzysztof; Paradowska-Kowal, Katarzyna; Sewerynek, Ewa.

Afiliação

Marcinowska-Suchowierska E; Department of Geriatrics and Gerontology, School of Public Health, Medical Centre of Postgraduate Education, Warsaw, Poland. emarcinowska@cmkp.edu.pl.
Blicharski T; Chair and Department of Rehabilitation and Orthopaedics, Medical University of Lublin, Lublin, Poland.
Wielosz E; Specialist Outpatient Clinic Reumed, Lublin, Poland.
Rell-Bakalarska M; Interdisciplinary Academy of Practical Medicine, Warsaw, Poland.
Duma K; Amgen Biotechnology, Warsaw, Poland.
Paradowska-Kowal K; Amgen Biotechnology, Warsaw, Poland.
Sewerynek E; Department of Endocrine Disorders and Bone Metabolism, Medical University of Lodz, Lodz, Poland.

Endokrynol Pol ; 74(3): 243-253, 2023.

Article em En | MEDLINE | ID: mdl-37695033

Assuntos

Denosumab; Osteoporose; Masculino; Humanos; Feminino; Polônia; Denosumab/uso terapêutico; Estudos Prospectivos; Osteoporose/tratamento farmacológico; Densidade Óssea

Palavras-chave

denosumab; osteoporosis; postmenopausal osteoporosis; therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Osteoporose / Denosumab Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Endokrynol Pol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google